In our study, 8 patients were identified with pathogenic or likely pathogenic germline mutations in non-Lynch syndrome genes (MUTYH, GALNT 12, POLE, MPL, ATM, and ERCC4), which indicated that there may be other genes outside of Lynch syndrome associated with endometrial cancer. Here, POLE is linked to endometrial cancer.